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Abstract 
Mitogen activated protein kinases (MAPKs) are part of conserved signal transduction 
modules in eukaryotes that are typically organised into three-tiered kinase cascades. The 
activation of MAPKs in these pathways is fully dependent on the bisphosphorylation of the 
TXY motif in the T-loop by the pertinent dual-specificity MAPK kinases (MAPKKs). The 
plant AtMPK9 is a member of an atypical class of MAPKs. Representatives of this MAPK 
family have TDY phosphoacceptor site, a long C-terminal extension, and lack the common 
MAPKK binding docking motif. Here, we present multiple in vitro and in vivo data that 
AtMPK9 is activated independently of any upstream MAPKKs but it is activated through 
autophosphorylation. We mapped the autophosphorylation sites by mass spectrometry to the 
TDY motif and to the C-terminal regulatory extension. We mutated the phosphoacceptor sites 
on the TDY, which confirmed the requirement for bisphorylation at this site for full kinase 
activity. Next, we demonstrated that the kinase inactive mutant form of AtMPK9 is not 
transphosphorylated on the TDY site when mixed with an active AtMPK9, implying that the 
mechanism of the autocatalytic phosphorylation is intramolecular. Furthermore, we show that 
in vivo AtMPK9 is activated by salt and is regulated by okadaic acid-sensitive phosphatases. 
We conclude that the plant AtMPK9 shows similarities to the mammalian atypical MAPKs, 
ERK7/8 in terms of MAPKK-independent activation mechanism. 
Key words: plant MAPK, TDY motif, atypical MAPK, MAPKK-independent, 
autophosphorylation, in vitro translation, AtMPK9 
Abbreviations used: CD, common docking domain; GOF, gain-of-function; LC/MS/MS, 
liquid chromatography tandem mass spectrometry; LOF, loss-of-function; MAPK and MPK, 
mitogen activated protein kinase; MAPKK and MKK, MAPK kinase; MBP, myelin basic 
protein; p-ERK, phospho-extracellular regulated kinase;  
Short (page heading) title: Autoactivation of a plant atypical MAPK, AtMPK9 
Summary statement: AtMPK9, a plant-specific mitogen-activated protein kinase is 
autoactivated independently of canonical MAPK cascades. Phosphoacceptor amino acid 
residues of the activation loop are bisphosphorylated by intramolecular autophosphorylation. 
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Introduction 
Reversible protein phosphorylation at serine, threonine and tyrosine residues is a ubiquitous 
mechanism of signal transduction in all eukaryotes. The mitogen-activated protein kinase 
(MAPK or MPK according to the plant nomenclature) family of protein kinases provide 
prevalent mechanisms for transducing extracellular mitogen and stress stimuli into cellular 
responses. In accordance with their versatile physiological functions, the hundreds of 
identified MAPK substrates range from transcription factors to cytoskeletal proteins and they 
are involved in many aspects of cellular functioning [1]. 
MAPKs are serine/threonine protein kinases and phosporylate their targets within a minimal 
S/T-P motif upon activation. The evolutionary conserved core signalling module of MAPK 
pathways is composed of a three-tiered cascade of kinases that activate the subsequent kinase 
by phosphorylation. More specifically, the extracellular signal-sensing receptor activates the 
most upstream component of the module, typically the serine/threonine MAPK kinase kinase 
(MAP3K or MEKK) that in turn phosphorylates MAPK kinase (MAP2K, MKK, or MEK). 
The activated dual-specificity MKK effectively phosphorylates both the tyrosine and 
threonine residues at the conserved TXY motif in the activation loop of the MAPK. The 
active MAPK than phosphorylates the pertinent protein substrates which leads to cellular 
responses. 
The majority of the MAPKs are activated within such canonical MAPK cascades and 
therefore classified as conventional MAPKs. The mammalian representatives of these 
MAPKs are extracellular signal-regulated kinases (ERK1/ERK2), c-Jun N-terminal kinases 
(JNKs), p38 and ERK5, which are phosphorylated by MKK1/MKK2, MKK4/MKK7, 
MKK3/MKK6 and MKK5, respectively [2]. The conventional MAPKs are all characterized 
by the presence of the TXY motif in their activation loop of the catalytic domain and require 
phosphorylation of both phosphoacceptor amino acids to become fully active. 
Another group of MAPKs, referred to as atypical MAPKs, are activated through a distinct, 
MKK-independent activation mechanism. In animal cells ERK3/4 and ERK7/8 belong to the 
atypical MAPKs. These ERKs show low level of homology, but similar structural 
organization, possessing a unique C-terminal extension with largely unknown functions [3]. 
Besides the C-terminal extension, ERK3/4 differs from classical MAPKs in phosphorylation 
requirements of their activation loop too. Both kinases lack the tyrosine phosphoacceptor site 
of the conserved TXY motif, but contain a SEG amino acid triplet and phosphorylation of the 
single serine residue within this motif is sufficient for their activation [4]. ERK3/4 cannot be 
phosphorylated and activated by any of the MKKs but instead they are phosphorylated by a 
group of I p21-activated kinases (I PAKs) which act as upstream activators for these MAPKs 
[5]. ERK7/8 resemble to ERK1/2 and ERK5 in having a TEY phosphoacceptor motif in the 
activation loop [6,7]. Despite to the canonical TXY motif, nor the rat ERK7 neither its human 
homologue, ERK8 require an upstream MKK for activation, but both residues are 
autophosphorylated involving an autocatalytic mechanism [8,9]. 
Plants feature the most extended MAPK family of all eukaryotes implying the versatility of 
these signalling mechanisms to regulate cellular functions. The plant MPKs were classified 
into four phylogenetic groups, designated A-D [10]. Comparing the sequences at the 
activation loops, MPKs fall into two types: those carrying the amino acid motif TEY (A-C 
group) and those with a plant-specific TDY phosphorylation motif (D group). The TEY-type 
MPKs possess the evolutionary conserved common docking (CD) domain, a characteristic 
feature of classical MAPKs. The CD contains an amino acid sequence with two adjacent 
acidic residues that are crucial for interaction with substrates and regulators of MAPKs such 
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as MKKs and phosphatases [11]. In accordance, it was shown that MPKs of the A-C groups 
can interact with and activated by pertinent MKKs and function in canonical MAPK pathways 
[12]. The D group of plant MAPKs that have TDY type of activation loop also differ from the 
classical MAPKs in several other aspects. Similarly to atypical MAPKs, they have a long C-
terminal extension and a diverged CD domain, wherein certain acidic residues are replaced 
with basic amino acids [13]. A recent study suggested that a member of the D group MPK, 
AtMPK8 is regulated both by MKK3 and by calmodulin [14]. However, it was not shown 
whether the activation is down to direct phosphorylation of the threonine and tyrosine 
residues at the TDY motif by MKK3. 
Here, we show that the D-type Arabidopsis MAPK, AtMPK9 is phosphorylated both at 
threonine and tyrosine residues of the TDY motif, which is required for the activity of the 
kinase. This phosphorylation relies on an intramolecular autocatalytic mechanism rather than 
on an upstream kinase. We identified serine residues of the C-terminal extension that also gets 
autophosphorylated. We also demonstrated that AtMPK9 is activated by salt treatment and 
regulated by okadaic acid-sensitive phosphatases in vivo. 
Materials and methods 
Plasmid construction, in vitro mutagenesis 
The AtMPK9 (AT3G18040) gene was amplified from cDNA library using iProof High-
Fidelity DNA polymerase (BioRad). The PCR products were inserted into the pEU3-NII-
HLICNot vector by ligation independent cloning (LIC) as described in [15]. This vector is a 
modification of what was described by Bardóczy et al. for wheat germ translation with His6 
affinity tag [16]. The myc-tagged, constitutively active, gain of function (GOF) mutant form 
of AtMKK4 was inserted into pEU3-NII-Gateway destination vector by Gateway cloning. 
PCR fragments of AtMPK9 mutants were cloned into pRT-HA vector [17] using NotI and 
NcoI restriction endonucleases (Fermentas) for protoplast transformation. The myc-tagged, 
GOF-MKK constructs were recloned into pK2GW7 vector [18] by Gateway conversion. Site 
directed mutagenesis of AtMPK9 were performed by QuikChange® Site-Directed 
Mutagenesis Kit (Stratagene) following the provided manual. XL-10 GOLD Escherichia coli 
competent cells (Stratagene) were transformed and plasmids were purified with PureLink 
Quick Plasmid Miniprep Kit (Life Technologies). All constructs and site directed mutagenesis 
were confirmed by sequencing. Plasmids for transient protoplast expression studies were 
purified by HiSpeed Plasmid Maxi Kit (Qiagen).  
In vitro transcription and cell-free translation 
To increase the efficiency of the in vitro transcription reaction, we generated linearized 
template DNA constructs with NotI (Fermentas). Transcription was performed by 
TranscriptAidTM T7 High Yield Transcription Kit (Fermentas) according to the suggested 
protocol. The mRNA was precipitated by ammonium acetate/ethanol mixture, dissolved in 1x 
SUB-AMIX and stored at -80 °C. Quality and quantity of mRNAs was verified on agarose gel 
electrophoresis. Cell-free translation was carried out in 20.6 μl final volume by addition of 5 
μL (15 μg) mRNA, 10 μL WEPRO® (Cell Free Sciences) solution, 0.8 μL creatine kinase (1 
mg/mL) and 5 μL 1x SUB-AMIX. Additional 0.5 μl of myc-GOF-AtMKK4 mRNA was 
added to the translation mixture for co-translation of myc-GOF-AtMKK4 with His6-AtMPK6 
leading to the active His6-AtMPK6. The translation solution was underlayed to 206 μL SUB-
AMIX in a sterile 96-well plate and the reaction was incubated for 20 hours at 20°C [15]. 
Plant cell culture, protoplast transformation and treatments 
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Columbia (Col-0) Arabidopsis thaliana root cell suspension culture was maintained according 
to Mathur and Koncz [19]. Isolation of protoplast and polyethylene glycol-mediated 
protoplast transformation were carried out as described by Anthony et al [20]. We used 5 μg 
plasmid DNAs to transform 2x105 protoplasts, and then cells were cultured for 16 h in dark at 
room temperature before harvesting. In case of myc-GOF-AtMKK co-transformation, 5:1 
ratio was applied; 5 μg of AtMPK9-HA coding vector and 1 μg of different myc-GOF-MKK 
constructs. For stress activation of AtMPK9 500 nM flg22, 250 mM NaCl, 20 nM H2O2 and 
cold treatment were implemented for 10 and 30 minutes. Phosphatase inhibitor treatment was 
made by addition of 100 nM or 1 μM okadaic acid (Sigma-Aldrich) and 100 μM or 1 mM 
sodium orthovanadate. 
Protein purification, phosphatase treatment, TEV protease cleavage 
In vitro translated proteins were purified by affinity chromatography on 10 μl TALON® 
Magnetic Beads (Clontech). 50 mM sodium phosphate buffer complemented with 10 mM 
imidazole, 300 mM NaCl, 0.1% Triton-X was used as wash and binding buffer. The resin was 
washed three times after 1 h incubation with total translation mixture at room temperature. 
Phosphatase treatment was carried out with λ Protein Phosphatase (New England Biolabs) for 
30 minutes at 30°C, and then washed three times with PBS, pH 7.4. TEV protease was 
affinity purified after bacterial protein expression using pTH24_TEV construct [21]. TEV 
protease cleavage was performed overnight and at 4 °C in 50 μl final volume with addition of 
2.5 μl 20X TEV Buffer (1 M Tris-HCl, pH 8.0, 10 mM EDTA), 0.5 μl 0.1 M DTT, 10 μl TEV 
protease to affinity purified proteins. Protein concentration was measured by Bradford 
reagent. Protoplast expressed AtMPK9-HA was purified with anti-HA agarose beads (Sigma-
Aldrich) after sonication of protoplasts in 100 μl Lacus buffer as described in [22]. 
In vitro protein kinase assays 
For kinase assays, either 300 ng of in vitro translated, His6-affinity purified kinase or anti-
HA-purified, in vivo expressed kinase from 30 μg total protein of protoplasts were used. The 
assay was carried out in 20 mM HEPES, pH 7.5, 100 μM ATP, 1 mM DTT, 15 mM MgCl2, 5 
mM EGTA, 5 μCi [γ-32P]ATP and 1 mg/ml myelin basic protein (Sigma-Aldrich) as a MAPK 
substrate in 16 μl final volume for 30 minutes at room temperature, then stopped by addition 
of 5x Laemmli SDS loading buffer. Samples were loaded onto a 15% SDS–PAG. The gel was 
fixed, stained with Coomassie Blue, dried and analyzed by autoradiography. 
Immunoblotting 
Proteins were separated using 10% SDS-PAGE, and subsequently blotted to PVDF membrane 
(Millipore) and blocked in 5% milk, PBS, 0.2% TWEEN-20, pH 7.4 solution for 1 hour. In 
the case of immunoblotting with p-ERK antibody (Cell Signaling), proteins were transferred 
onto nitrocellulose membrane and blocking was performed in phosphate free solution: 5% 
BSA, TBS, 0.2 % TWEEN-20, pH 7.4. Anti-HA-peroxidase (Roche), anti-c-myc-peroxidase 
(Roche), goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology) and p-ERK (Cell Signaling) 
antibodies were used. When multiple antibodies were used in successions, the membrane was 
stripped with 20 ml freshly made stripping buffer (200 mM glycine, 1% TWEEN-20 and 
0.1% SDS,pH 2.2). 
 
LC–MS/MS analysis 
Phosphorylation reaction mixtures were separated by 10% SDS-PAGE, bands corresponding 
to AtMPK9 protein were excised from the gel and subjected to in-gel digestion using side-
chain-protected porcine trypsin [23]. Approximately 20% of the resulting peptide mixtures 
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were subjected directly to LC-MS/MS analyses and the other 80% was enriched for 
phosphopeptides using TiO2 [24]. LC-MS/MS experiments were performed in “triple play” 
acquisition mode using a Thermo LCQ-Fleet ion trap mass spectrometer on-line coupled to an 
Eldex nanoHPLC system. Raw data were converted into peak lists using the Mascot Distiller 
software applying default LCQ_Fleet opt processing parameters. Database searches were 
performed using the ProteinProspector search engine (version 5.12.2) with the following 
parameters: database: Swissprot or user database containing the sequences of wild-type and 
mutant MPK9s’; enzyme: trypsin allowing 1 missed cleavage; mass accuracies: 0.6 Da for 
precursors and 1 Da for fragment ions (both monoisotopic); modifications: fixed: 
carbamidomethylation of Cys’s, variable: methionine oxidation, pyroglutamic acid formation 
from peptide N-terminal Gln residues and acetylation of protein N-termini allowing maximum 
2 modifications per peptide. For phosphopeptide identifications the same parameters were 
applied except that 2 missed cleavages and phosphorylation of Ser/Thr/Tyr residues with 
maximum 3 variable modifications per peptide were allowed. Acceptance parameters: score: 
22 and 15, E value: 0.01 and 0.05 for protein and peptide identifications, respectively, SLIP 
(site localization in the peptide) score: 6 [25]. Samples were also analyzed in a data-dependent 
acquisition mode using a Waters Q-TOF Premier mass spectrometer online coupled to a 
nanoAquity UPLC system. From the raw data peaklists were generated by the Mascot 
Distiller software using default QTOF.opt processing parameters. Database searches were 
conducted as described above except that mass accuracies were set to 20 and 100 ppm for 
precursor and fragment ions (both monoisotopic), respectively allowing 45 ppm systematic 
error for precursor ions; and ESI-Q-TOF was specified as instrument. All phosphopeptide 
identifications were inspected manually. 
Results 
The in vitro translated AtMPK9 has an intrinsically high kinase activity 
The His6-tagged AtMPK6 and AtMPK9 were taken as representatives of A and D groups of 
plant MPKs and were synthesized by wheat-germ based in vitro translation. The purified 
AtMPK6 and AtMPK9 showed a clear difference in the migration pattern on SDS-PAG. In 
contrast to the single, definitive band of AtMPK6, gel electrophoretic separation of AtMPK9 
produced multiple protein bands that shifted upwards. Incubation of AtMPK9 with λ 
phosphatase converted this smeared migration pattern into a single band on SDS-PAG (Figure 
1A), suggesting that the differently migrating forms are due to phosphorylation. In addition, 
AtMPK9 had a significantly higher myelin basic protein (MBP) kinase activity than the in 
vitro translated AtMPK6 (Figure 1B). 
Bisphosphorylation of the TXY phosphoacceptor motif in the T-loop is known to be fully 
required for MAPK activation [22]. To determine the phosphorylation state of the TXY motif 
on AtMPK6 and AtMPK9, we used a polyclonal antibody that was developed against the 
double phosphorylated TEY amino acid triplet of the animal ERK1. The in vitro translated 
AtMPK6 was only recognized by phospo-ERK (p-ERK) antibody when the cognate 
constitutively active gain of function (GOF) GOF-AtMKK4 was co-translated with it, 
suggesting that AtMKK4 is inevitable for the phosphorylation of TEY on AtMPK6. On the 
contrary, the in vitro translated recombinant AtMPK9 was recognized by the same antibody 
without the need to add MKKs (Figure 1B). We confirmed the phosphorylation of the 
threonine and tyrosine residues within the characteristic TDY motif of AtMPK9 by mass 
spectrometry (MS) analysis. The corresponding [173-191] peptide to TDY was present both 
in mono- and bisphosphorylated forms and with MS/MS analysis we could assign the 
phosphorylation to Tyr-187 in the monophosphorylated peptide (Suppl. figure 1). 
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The phosphorylation of TDY motif on AtMPK9 is fully required for the kinase activity 
The majority of MAPKs require double phosphorylation of the TXY motif to be fully active. 
We exchanged in combinations the threonine and tyrosine phosphoacceptor sites of the TDY 
motif of AtMPK9 to non-phosporylatable alanine and phenylalanine by in vitro mutagenesis 
to address whether the activity of AtMPK9 depends on bisphosphorylation of the TDY 
phosphoacceptor site. Single T185A, Y187F and double T185A/Y187F mutants of AtMPK9 
were produced by in vitro translation. All three of these mutant AtMPK9 forms migrated as 
distinct bands on SDS-PAG, whereas the wild-type AtMPK9 was separated in a diffuse band 
as was observed before (Figure 2A). To confirm the lack of phosphorylation at the TXY motif 
of these three mutant AtMPK9 forms, tryptic digests of the proteins were analyzed by data-
dependent LC/MS/MS. The MS data verified the amino acid exchanges performed by in vitro 
mutagenesis. More importantly, phosphotyrosine and phosphothreonine were detected in the 
T185A and Y187F mutants, respectively (Figure 2B) suggesting that the single replacement 
of either threonine or tyrosine in the TDY motif did not influence the phosphorylation of the 
non-exchanged phosphoacceptor site. Using these mutant AtMPK9 forms, we addressed how 
the phosphorylation state of the TDY motif impacts on the kinase activity of AtMPK9. None 
of the mutant AtMPK9 forms had any detectable activity towards MBP in vitro (Figure 2A, 
bottom panel). These results suggested that phosphorylation of both phosphoacceptor amino 
acids in the TDY motif is essential for the activation of AtMPK9. 
Activation of AtMPK9 does not depend on MKKs 
 
In plants, there is no evidence for activation of MPKs that does not involve upstream MKKs. 
MAPK activation by MKKs typically involves their specific interactions. However, in 
agreement with published systematic yeast two hybrid interaction screens among MKKs and 
MPKs, we also could not detect interaction of AtMPK9 with MKKs by yeast two hybrid 
assay (data not shown and [26]). Alternatively, AtMPK9 interaction with and activation by 
MKKs might rely on yet unidentified scaffold proteins present in Arabidopsis cells [27]. To 
examine this possibility, we expressed HA-tagged AtMPK9 and constitutively active mutants 
of Arabidopsis MKKs in transformed protoplast. First, we set out to determine the 
physiologically relevant stimuli that activate AtMPK9 in vivo. To do this, we treated cells 
with salt, cold, H2O2, and the pathogenic elicitor, flg22, immunoprecipitated the tagged 
AtMPK9-HA protein and performed in vitro kinase activity measurements. All tested stress 
conditions, except cold increased the AtMPK9 kinase activity in 10 minutes and salt treatment 
showed to be the most pronounced effector (data not shown). Accordingly, we used 10 min 
treatment with 250 mM salt to elicit kinase activity of AtMPK9 in the subsequent experiment. 
Next, we co-transformed AtMPK9 with a panel of constitutively active, gain-of-function 
MKKs (GOF-MKK), representing each plant MKK subgroup. The kinase activity-elevation 
of AtMPK9 was negligible with any of the GOF-MKKs in comparison to the salt treatment of 
protoplasts (Figure 3). The bisphosphorylated TDY motif and the high catalytic activity of in 
vitro translated AtMPK9, the lack of interaction with MKKs and the inability to be activated 
by GOF-MKKs in cells all indicate an MKK independent but autophosphorylation-dependent 
activation mechanism. 
 
AtMPK9 is activated by autophosphorylation 
In order to see whether the phosphorylation of the T-loop is indeed dependent on the kinase 
activity of AtMPK9, we produced a catalytically inactive, loss-of-function (LOF) mutant form 
of AtMPK9 by replacing one of the lysines of the ATP binding site. SDS-PAGE separation of 
the affinity-purified LOF-AtMPK9 showed a single distinct band, a migration pattern which 
was similar to that of the phosphoacceptor-site mutants (Figure 4A). We confirmed by in vitro 
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kinase assay that the LOF-AtMPK9 is inactive and next we looked to see whether the 
phosphorylation of the TDY motif is dependent on the AtMPK9 kinase activity. The active in 
vitro translated AtMPK9 but not the LOF-AtMPK9 was detected by the p-ERK antibody. The 
lack of TDY phosphorylation of the LOF-AtMPK9 on one hand rules out that there is an 
unknown protein kinase in the wheat germ extract used for in vitro translation that 
phosphorylates AtMPK9, while on the other hand suggests that AtMPK9 activity is required 
for TDY phosphorylation, likely through an autocatalytic reaction (Figure 4A). MS analysis 
was in agreement with the data obtained by immunoblot with p-ERK antibody; no 
phosphorylated tryptic peptide spanning the TDY motif [173-191] of LOF-AtMPK9 could be 
detected. 
To corroborate the conclusion that the in vitro translated AtMPK9 is autophosphorylated, we 
set out to determine whether or not the LOF-AtMPK9 was phosphorylated on the TDY sites 
in vivo. Protoplasts were transformed to express WT-AtMPK9 and LOF-AtMPK9 and treated 
with salt. Western blot analysis with p-ERK antibody demonstrated that the TDY motif of 
WT-AtMPK9 became phosphorylated under stress conditions (Figure 4B). In contrast, the 
treated and non-treated LOF samples were indistinguishable; none of them were detectable 
with the p-ERK antibody. In vitro kinase activities of HA-immunoprecipitated samples were 
also measured and the obtained data were in accordance with the Western blot results; only 
the salt-treated WT-AtMPK9 was active to phosphorylate MBP. 
It is known that MAPKs are negatively regulated by multiple phosphatases of Tyr-, Ser/Thr-, 
and dual-specificities. To reveal whether or not phosphatases regulate the TDY 
phosphorylation and activity of AtMPK9 in vivo, we treated protoplasts expressing WT-
AtMPK9 or LOF-AtMPK9 with two different phosphatase inhibitor, okadaic acid inhibiting 
PP2A, PP2B and to a lesser extent PP1 and with orthovanadate that inhibits Tyr and dual-
specificity phosphatases. Analysing TDY phosphorylation state with p-ERK antibody showed 
that okadaic acid treatment led to a dramatic increase in TDY phosphorylation of WT-
AtMPK9 (Figure 5), while orthovanadate had hardly any effect (data not sown). The activity 
of WT-AtMPK9 in these samples paralleled the TDY phosphorylation. Importantly, none of 
the phosphatase inhibitor treatments led to TDY loop phosphorylation of the kinase inactive, 
LOF-AtMPK9 mutant. Collectively, these results show that AtMPK9 is activated by 
autophosphorylation and this is regulated directly or indirectly by okadaic acid sensitive 
phosphatases in vivo.  
AtMPK9 is phosphorylated by an intramolecular mechanism 
 
In most of the cases, autophosphorylation is an intermolecular reaction in which one kinase 
molecule phosphorylates another closeby kinase molecule, but intramolecular kinase 
autophosphorylation has also been described [28]. In order to distinguish between these two 
autocatalytic processes, first, we dephosphorylated the affinity-bead coupled, AtMPK9 by λ 
phosphatase and tested whether it can still be autophosphorylated. In accordance with our 
previous results, phosphatase treatment resulted in a down-shift of WT-AtMPK9 on SDS-
PAG and migrated to the same position as the LOF-AtMPK9 (Figure 6A). Next, we run 
kinase reactions with the purified λ phosphatase treated and untreated AtMPK9 samples and 
detected the phosphorylated forms on an autoradiogam. Both samples showed 
phopshorylation of AtMPK9 that was even stronger when WT-AtMPK9 was treated with the 
λ phosphatase (Figure 6B upper panel). The MBP kinase activity again mirrored the level of 
autophosphorylation, indicating that the phosphorylation and activity of purified AtMPK9 
was efficiently restored by an autocatalytic mechanism (Figure 6B bottom panel). Lastly, we 
set out to test whether an active AtMPK9 can transphosphorylate the kinase inactive LOF-
AtMPK9 mutant. We immobilized LOF-AtMPK9 kinase to beads, added active AtMPK9 to it 
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and make the kinase reaction. Subsequently, we recovered the bead-immobilized LOF-
AtMPK9 and run on SDS-PAG. No phosphorylation could be detected on the autoradiogram, 
implying that the LOF-AtMPK9 mutant cannot be transphosphorylated by the active AtMPK9 
(Figure 6B upper panel). These in vitro kinase experiments show that AtMPK9 is activated by 
intramolecular autophosphorylation. 
 
The C-terminal domain of AtMPK9 is also autophosphorylated at multiple sites 
The diffuse migration pattern of AtMPK9 hints that the kinase is phosphorylated on multiple 
sites. According to the LC/MS/MS data, the active and inactive forms of AtMPK9 hold 
different phosphorylation patterns in their C-terminal extensions. Beside the TDY motif, Ser-
401, Ser-443, and Ser-464 were also phosphorylated in the wild-type AtMPK9 but none of 
these residues were detected to be phosphorylated with the catalytically inactive LOF-
AtMPK9 mutant form. Interestingly, Ser-464 is followed by an alanine residue instead of a 
proline, implying that AtMPK9 is capable of phosphorylating serine residues that do not fulfil 
the S/T-P definition of MAPK phosphorylation sites (Suppl. figure 2). 
Discussion 
 
The hallmark of the conventional MAPKs is the TXY amino acid triplet at the activation loop 
that is phosphorylated on both phosphoacceptor residues by the cognate MAPKKs to fully 
activate the kinase. This double phosphorylation is accomplished by dual-specificity upstream 
MAPKKs in two steps, first the tyrosine then the threonine is modified that results in a four-
magnitude increase in the activity [29]. Selective activation of MAPKs is ensured by 
interaction between the C-terminally located CD of MAPKs and its complementary docking 
domain of the pertinent interacting proteins [11]. 
Several experiments have demonstrated that phosphorylation by MAPKKs is not the sole 
mechanisms of MAPK activation. Some of the atypical MAPKs have to be phosphorylated on 
a single serine residue by IPAKs for elicitation [5]. Other representatives of atypical MAPKs, 
such as ERK7/8 gain their activity by intramolecular autophosphorylation on both 
phosphoacceptor sites of the TXY motif [8,9]. Surprisingly, p38α, a conventional MAPK -
beside the prototypical MAPKK phosphorylation, also could be activated by an autocatalytic 
manner. This alternative activation mechanism is induced by direct interaction of p38α with 
TGF-Beta Activated Kinase 1/MAP3K7 Binding Protein 1 (TAB1) that results in MAPKK-
independent dual phosphorylation of the TGY motif of the activation loop [30]. These results 
hint that regulation of MAPKs is more sophisticated than it was previously anticipated, and 
authophosphorylation might also be a more general activation mechanism of MAPKs that can 
coexist with the canonical activation through MAPKKs. 
The Arabidopsis genome encodes 20 MPKs but only a handful of them were studied in 
details. These include AtMPK3, AtMPK4 and AtMPK6 that belong to the classical MAPKs 
carrying the TEY motif in their activation loops. These A and B group members of MPKs 
were shown to be activated by dual specificity MKKs [31]. MPKs that belong the C group 
was also proved to be activated through the canonical activation mechanism involving an 
upstream MKK, AtMKK3 [32]. In comparison to the TEY motif containing plant MPKs, 
much less data is available for the structurally most different MPKs with TDY activation loop 
in the D group [14,32]. AtMPK8 is the only D group MAPKs that was studied and was shown 
to be activated through phosphorylation by AtMKK3 [14]. Surprisingly, the other suggested 
activation process –direct interaction with calmodulin– does not rely on phosphorylation of 
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threonine and tyrosine residues of the T-loop since the calmodulin induced activity elevation 
is similar in wild-type and the TDY mutant form of AtMPK8. 
In this study, we have shown important insights into the regulation of AtMPK9, another 
representative of D group MPKs. In contrast to AtMPK6, the in vitro translated AtMPK9 
showed high kinase activity without the addition of upstream MKKs. This high kinase activity 
was accompanied by dual phosphorylation of the TDY motif of the activation loop as it was 
demonstrated by immunoblot using p-ERK antibody. Phosphorylation of both 
phosphoacceptor amino acids within the TDY motif is essential for kinase activity since in 
vitro mutagenesis of either the threonine or tyrosine residue drastically reduced the activity of 
in vitro translated AtMPK9 mutants, even though non-mutated residues were phosphorylated 
according to MS/MS analysis. The MKK independent activation mechanism has been 
corroborated by in vivo studies using transformed Arabidopsis protoplasts. AtMPK9 was 
activated upon salt treatment when expressed in protoplasts, while none of the constitutively 
active mutant MKKs were able to activate AtMPK9. Furthermore, contrary to wild-type 
AtMPK9, the protoplast-expressed inactive mutant version of AtMPK9 was not recognized by 
p-ERK antibody following salt treatment, again indicating that the T-loop phosphorylation is 
an autocatalytic process. Application of phosphatase inhibitors provided an additional line of 
evidence for autophosphorylation of AtMPK9 and its regulation by phosphatases. Treatment 
of cells expressing wild-type AtMPK9 and LOF-AtMPK9 resulted in dramatically increased 
phosphorylation and activation of wild-type AtMPK9, while the phosphorylation of TDY 
motif in the kinase inactive LOF-AtMPK9 was insignificant following okadaic acid treatment. 
Finally, mass spectrometry analysis of in vitro translated and affinity-purified AtMPK9 
complex failed to indentify any interacting, endogenous protein kinases of wheat germ extract 
(data not shown). These results collectively suggest that activation of AtMPK9 does not rely 
on upstream kinase, but involves an autophosphorylation mechanism and signalling inputs by 
protein phosphatases. According to our in vitro kinase activity assays, this 
autophosphorylation is intramolecular rather than intermolecular since the inactive LOF-
AtMPK9 mutant was not phosphorylated when mixed with an active AtMPK9. LC/MS/MS 
analysis of the tryptic digests demonstrated that the C- terminus of the kinase is also 
autophosphorylated: 3 serines at this unstructured domain were phosphorylated, but only with 
the wild-type AtMPK9. Interestingly, one of these residues does not fulfil the minimal 
requirement of the MAPK phosphorylation motif since the modified serine is not followed by 
a proline. These data imply that AtMPK9 has a broader phospho-site recognition specificity 
that what we know for canonical MAPKs. 
A systematic screen for the interactions of MKKs and MPKs using yeast two hybrid failed to 
identify MKK partners for most D-type MPKs including  AtMPK9 [26]. At the same time, 
our in vivo AtMPK9 activation experiments in transformed protoplasts suggested that 
AtMPK9 does not rely on any MKKs. According to our results, the in vitro translated 
AtMPK9 is activated by an intramolecular autocatalytic mechanism. This is in contrast to 
what has been suggested for AtMPK8, a close member within the D group, which is in 
parallel and independently activated by upstream MKK and calmodulin [14]. AtMPK9 
activation is not dependent on MKKs and is strictly reliant on the autophosphorylation of both 
phosphoacceptor residues of the TDY amino acid triplet. The D-type MPKs display high 
homology in their kinase domains but are divergent in their C-termini (Suppl. figure 3). 
Therefore, representatives of this kinase group might be regulated by diverse mechanisms and 
the C-terminal domain might be a crucial component of controlling the activity of D-type 
MPKs. Considering this putative function of the C-terminus, phosphorylation of serines in 
this domain of AtMPK9 is also expected to have a physiological function in regulating the 
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kinase activity, but further work is necessary to determine the biochemical mode of this 
regulation. 
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Figure 1 In vitro translated AtMPK9 is phosphorylated and possesses high kinase 
activity. 
(A) His6-AtMPK9; His6-AtMPK9 that was dephosphorylated by λ Protein Phosphatase 
treatment, and His6-AtMPK6 were separated by 10% SDS-PAGE and stained with Coomassie 
Blue. 1 μg of in vitro translated and purified protein samples were loaded. 
(B) His6-AtMPK9; His6-AtMPK6, and His6-AtMPK6 co-translatated with myc-MKK4GOF 
were in vitro translated and affinity purified. Samples were analysed by 10% SDS-PAGE 
stained with Coomassie Blue (upper panel). In vitro kinase assays were carried out with 300 
ng of purified proteins using [γ-32P]ATP and MBP as artificial substrate, run on 15% SDS-
PAG and the autoradiography is shown (middle panel). Immunoblot of 300 ng of each of the 
in vitro translated, purified proteins were probed with p-ERK antibody to detect 
phosphorylation of the Thr-X-Tyr motif of the activation loop of MAP kinases (bottom 
panel). 
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Figure 2 AtMPK9 mutants of the phosphoacceptor sites in the TDY motif of the T-loop 
are all inactive 
(A) 1 μg in vitro translated and metal chelate affinity purified His6-AtMPK9 (WT) and T-loop 
phosphorylation site mutant forms His6-AtMPK9-T185A/Y187F, His6-AtMPK9-T185A, 
His6-AtMPK9-Y187F were separated by 10 % SDS-PAGE and stained with Coomassie Blue 
(upper panel). 300 ng of in vitro translated and purified proteins were subjected to in vitro 
kinase assay and analysed as decribed in Figure 1 (lower panel).  
(B) TDY triplet corresponding phosphopeptides identified in the in vitro translated and 
purified AtMPK9 mutants. Collision induced dissociation (CID) spectra of 
Upper panel: m/z: 1112.5 (2+) representing VSFNDAPSAIFWT(Phospho)DFVATR in the 
Tyr-187 mutant protein. The phosphorylation site is Thr-185 (see fragment ions y5 
(unmodified) and y7 (phosphorylated ). 
Lower panel: m/z: 1105.5 (2+) representing VSFNDAPSAIFWADY(Phospho)VATR in the 
Thr-185 mutant protein. Site of phosphorylation is Tyr-187 (see fragment ions y4 
(unmodified) and y5 (phosphorylated ). Peptide fragments are labeled according to the 
nomenclature of Biemann et al [33]. Marks 0 and * indicate water and ammonia loss from the 
corresponding fragment ions, respectively. –P stands for the 98-Da neutral loss of phosphoric 
 acid characteristic of Ser/Thr phosphorylation. 
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Figure 3 AtMPK9 is activated by salt treatment but not by any of the Arabidopsis gain-
of-function MKKs in vivo in transformed cultured cells 
AtMPK9-HA was transformed into Arabidopsis protoplasts, cells were treated with 250 mM 
NaCl for 10 min (lane 1) or a panel of gain-of-function (GOF). myc-GOF-MKKs (GOF-
MKK1, GOF-MKK2, GOF-MKK3, GOF-MKK4, GOF-MKK5, GOF-MKK6, GOF-MKK7, 
GOF-MKK9) were co-transformed with AtMPK9-HA. Transformed cells were harvested 
after 16 hours incubation. In vitro kinase activity of HA antibody immunoprecipitated 
AtMPK9 was measured as in Figure 1 (upper panel). 30 μg of total protein was analysed by 
immunoblotting with anti-HA and anti-c-myc antibodies. 
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Figure 4 T-loop phosphorylation pattern of in vitro translated and protoplast expressed 
AtMPK9 suggests autocatalytic activation mechanism 
(A) In vitro translated and 1 μg purified wild-type His6-AtMPK9 (WT) and its kinase inactive 
mutant form (LOF) His6-AtMPK9 were analysed on 10% SDS-PAG with Coomassie Blue 
staining (upper panel). Kinase assay was performed with 300 ng affinity purified proteins 
(middle panel). Phosphorylation of the TDY motif was detected by immunoblotting with the  
p-ERK antibody (bottom panel). 
(B) Wild-type (WT) and loss-of-function (LOF) AtMPK9-HA constructs were transformed 
into Arabidopsis protoplasts and activated or not by 250 mM NaCl. AtMPK9 was 
immunoprecipitated with anti-HA-agarose from 30 μg of total protein extract and kinase 
activity was measured (upper panel). Phosphorylation of the TDY motif was detected by 
immunoblotting with the p-ERK antibody using 30 μg of total protein extract (middle panel). 
AtMPK9-HA was detected by immunoblot using peroxidase conjugated HA antibody (bottom 
panel). 
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Figure 5 Phosphatase inhibitor, okadaic acid treatment results in phosphorylation and 
activation of protoplast expressed wild-type AtMPK9 but not the kinase inactive mutant 
form 
Wild-type and kinase inactive mutant forms of AtMPK9 were expressed in protoplasts. 
Following 1 hour okadaic acid treatment, 30 μg of total protein was analysed by 
immunoblotting with p-ERK and HA antibodies, and in vitro kinase activity of 
immunoprecipitated AtMPK9 was measured.   
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Figure 6 The in vitro translated AtMPK9 is phosphorylated by an intramolecular 
mechanism 
(A) Wild-type (WT) and kinase inactive mutant (LOF) forms of His6-AtMPK9 were 
synthesized by in vitro translation, affinity purified, and treated or not with λ Protein 
Phosphatase. 1 μg of proteins were separated by SDS-PAGE and stained with Coomassie 
Blue. 
(B) In vitro kinase assay was performed with 300 ng affinity bead bound wild-type, 
dephosphorylated wild-type and loss of function AtMPK9 samples to test autophoshorylation. 
Transphosphorylation was also assessed by the addition of 50 ng of WT-AtMPK9 to 500 ng 
bead bound inactive His6-LOF-AtMPK9 (last lane, +). Samples were separated on 10% SDS-
PAGE and evaluated by autoradiography. In vitro activity of the kinases was tested by using 
MBP as artificial substrate. 
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Figure 7 Identified phosphorylated amino acid residues of AtMPK9 
The 3D structure of AtMPK9 was generated by I-TASSER online prediction program [34]. 
Images were rendered using UCSF Chimera [35]. Phosphorylated amino acid residues 
(Thr185, Tyr187, Ser401, Ser443, Ser464) are indicated with black, kinase domain (1-314 
AA) with dark grey and the C-terminal domain with light grey colour. 
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